Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

September 11, 2019

Primary Completion Date

October 22, 2024

Study Completion Date

November 30, 2026

Conditions
Pancreatic CancerSurgeryEpidural BlockDexamethasoneOverall Survival
Interventions
OTHER

Epidural block

Epidural block (with 0.375% ropivacaine) is performed during surgery. Patient-controlled epidural analgesia (with a mixture of 0.12% ropivacaine and 0.5 microgram/ml sufentanyl) is provided after surgery.

DRUG

Dexamethasone

Dexamethasone (10 mg) is administered intravenously before anesthesia induction.

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors
collaborator

Peking University Cancer Hospital & Institute

OTHER

collaborator

The Second Affiliated Hospital of Chongqing Medical University

OTHER

lead

Peking University First Hospital

OTHER